Kailera Therapeutics, Inc. ($KLRA)
Filing Information
| Accession Number | 0001193125-26-164407 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 20, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
43,642,336
Total Value
$25,000,000.00
P&L
+57.6% (+$14,395,688.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 20, 2026 | Conversion | 16,875,000 | โ | โ | 16,875,000 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Apr 20, 2026 | Conversion | 4,145,768 | โ | โ | 21,020,768 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Apr 20, 2026 | Purchase | 1,562,500 | $16.00 | $25,000,000.00 | 22,583,268 | Indirect | See footnotes | View Details | |
Director | Series A-1 Preferred Stock | Derivative | Apr 20, 2026 | Conversion | 16,875,000 | $0.00 | $0.00 | 0 | Indirect | See footnotes | View Details | |
Director | Series B Preferred Stock | Derivative | Apr 20, 2026 | Conversion | 4,145,768 | $0.00 | $0.00 | 0 | Indirect | See footnotes | View Details | |
Director | Stock Option (right to buy) | Derivative | Apr 16, 2026 | Grant/Award | 38,300 | $0.00 | $0.00 | 38,300 | Direct | โ | View Details |